# Shenzhen Chenghui Medical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-chenghui-medical-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Latest round: Series B (Oct 13, 2025)
- Investors on record: 1

## About

Based in Shenzhen, China and founded in 2022, Chenghui Medical is a company that develops, manufactures and distributes molecular diagnostic instruments and reagents. 

In February 2026, Shenzhen Chenghui Medical Technology Co., Ltd. closed a round of series B+ funding from Dongguan Biotechnology Industry Development Fund.

Shenzhen Chenghui Medical Technology Co., Ltd. primarily develops fully automated nucleic acid detection systems and related reagents based on microfluidics. The company's ultra-multiplexed molecular POCT (point-of-care testing) platform can fully automatically performs column extraction and eight-chamber QPCR (quantitative polymerase chain reaction) reactions within a fully enclosed centrifugal microfluidic chip. The company's products are used in clinical diagnosis, epidemic prevention and control, and other fields.

The company generates revenue from the research, development, production, and sales of its products and other related services. 

The company will use the series B+ funding to continue to innovate in the field of molecular diagnostic instruments and reagents research and development.

## Funding rounds

- Series B, Oct 13, 2025 — Guangdong Boji Venture Capital Management

## Investors

- Guangdong Boji Venture Capital Management (https://capitalatlas.ai/funds/guangdong-boji-venture-capital-management) — Series B